PCR (Polymerase Chain Reaction) is one of the most widely used tools in molecular biology, powering breakthroughs in research, diagnostics, forensic science, and public health. As the demand for accuracy, speed, and reagent stability grows—especially during global health emergencies—Hzymes Biotech is leading the next evolution of PCR with its innovative Whole-block Taq antibody technology.

Who Is Hzymes Biotech?

Hzymes Biotech is a cutting-edge biotechnology company dedicated to enhancing molecular diagnostics and life sciences through enzyme innovation. With a strong foundation in research and development, Hzymes has been at the forefront of optimizing PCR enzymes, especially Taq DNA polymerase, to meet the needs of modern laboratories and testing organizations.

The Challenges with Traditional PCR Reagents

While hot-start PCR using antibody-modified Taq DNA polymerase has improved specificity, conventional reagents still struggle with:

Non-specific amplification, especially in multiplex PCR setups
Degradation of primers and probes due to 5’→3′ exonuclease activity
Stability issues during storage at 4°C or room temperature for extended periods
These problems reduce testing accuracy and complicate logistics for diagnostic labs, especially during pandemics or in remote areas.

Hzymes’ Whole-Block Antibody: A Breakthrough in PCR Efficiency

To solve these persistent problems, Hzymes developed a Whole-block Taq antibody solution that fully inhibits both:

5’→3′ polymerase activity
5’→3′ exonuclease activity
Using advanced B-cell cloning, single-cell optofluidic screening (Beacon platform), and ELISA validation, Hzymes’ research team identified a synergistic combination of three monoclonal antibodies that deliver:

>99% inhibition of both key enzymatic activities at 70°C
Fast activation, with >95% enzyme activity released within 30 seconds at 95°C
Superior reagent stability, even after 28 days at 37°C

Key Product Benefits

Whole-block Precision: Minimize non-specific amplification and false positives
Rapid Start: Maximize lab efficiency with ultra-fast enzyme activation
Broad Compatibility: Works with wild-type and engineered Taq DNA polymerases
Strict Quality Control: Free of nuclease residue and host DNA contamination

Proven Performance in Critical Applications

1. Pre-mixed Reagent Stability

In side-by-side tests, Hzymes’ Whole-block Taq antibody maintained superior amplification efficiency compared to conventional products after 28 days at 37°C—ideal for logistics-heavy operations or global distribution.

2. Specificity in Multiplex PCR

In forensic testing scenarios, Hzymes’ enzyme blend drastically reduced non-specific bands and increased clarity in multi-target assays.

Why Labs Choose Hzymes for PCR Solutions

Scalable for pandemic response: Proven performance during COVID-19 and African Swine Fever testing
Designed for global labs: Reagents remain stable across wide temperature ranges
High-quality support: Backed by a professional R&D team and customer-focused service

Explore the Future of PCR with Hzymes

Whether you’re a diagnostics lab, research institute, or biotech company, Hzymes Biotech’s Whole-block Taq antibody sets a new gold standard for reliable, efficient, and high-performance PCR.

Contact: info@hzymes.com today to request a sample or technical data sheet.

Visit: https://hzymesbiotech.com/ to learn more about our full range of PCR enzyme solutions.